Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death. Gene therapy was established as a new strategy for treating HCC. To explore the potential delivery system to support the gene therapy of HCC, negatively charged liposomal delivery system was used to deliver miR-221...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Nanomedicine
Autori principali: Zhang, Wendian, Peng, Fangqi, Zhou, Taotao, Huang, Yifei, Zhang, Li, Ye, Peng, Lu, Miao, Yang, Guang, Gai, Yongkang, Yang, Tan, Ma, Xiang, Xiang, Guangya
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2015
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4524461/
https://ncbi.nlm.nih.gov/pubmed/26251599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S79598
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi